Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient
1 other identifier
interventional
50
1 country
2
Brief Summary
SARS-CoV-2 is the coronavirus responsible for developing the disease known as COVID-19. Its evolution can range from an asymptomatic course, to rapidly evolve and cause an acute respiratory syndrome. In addition to respiratory symptoms, is also has an impact on the neuromuscular systems. Therefore, the additional inactivity for hospitalization, negatively influences the loss of muscular, cardiovascular and metabolic fitness. In view of this, it is recommended that early post-acute rehabilitation be continued after the hospital phase to increase levels of physical activity, which can also be continued with long-term telerehabilitation. This project would offer a free service of asynchronous physical telerehabilitation for the patient that is easy to implement and follow up. For this purpose, patients will be recruited at the time of discharge from the Hospital Provincial Nuestra Señora de Gracia (HPNSG) and the Hospital Royo Villanova (HRV) in Zaragoza and two intervention groups with the same physical therapy and educational programme will be carried out. The experimental group will be carried out by means of home telerehabilitation, while the control group will receive the programme in an explanatory booklet. The main objective is to analyse the preliminary efficacy on physical fitness of a 12-week physical therapy and therapeutic education programme using asynchronous telerehabilitation in post-COVID-19 patients, and to compare its effects with patients who have undergone the same programme, but in a non-telematic format. The secondary objective is to analyze the feasibility of a physical home-based asynchronous telerehabilitation programme in post-COVID-19 patients. Hypothesis: the implementation of a 12-week programme of physical therapy and therapeutic education using asynchronous telerehabilitation software is feasible and preliminarily effective in increasing physical fitness as well as adherence to treatment, and in the improvement of psychosocial factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedStudy Start
First participant enrolled
April 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 11, 2023
March 1, 2022
1.2 years
March 1, 2021
April 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fatigue Severity Level
Change in fatigue severity level. Fatigue will be assessed with the Fatigue Severity Scale (FSS). The Fatigue Severity Scale is a self-reported scale composed of 9 items. Each item is rated from 1 to 7 (from 1=strongly disagree to 7=strongly agree). In the FSS, a mean of less than 4 points is considered to be no fatigue and more than 4 is considered to present fatigue. The higher the score, the greater the severity of fatigue.
Pre-intervention (day 1); after intervention (day 84); follow up 1 (3 months after intervention); follow up 2 (6 months after intervention).
Secondary Outcomes (13)
Adherence
Pre-intervention (day 1); during intervention (every 15 days during intervention); after intervention (day 84).
Engagement
Pre-intervention (day 1); during intervention (every 15 days during intervention); after intervention (day 84).
Satisfaction level
Pre-intervention (day 1); during intervention (every 15 days during intervention); after intervention (day 84).
Incidents
Pre-intervention (day 1); during intervention (every 15 days during intervention); after intervention (day 84).
Maximum Leg Strength Endurance
Pre-intervention (1 day); after intervention (day 84).
- +8 more secondary outcomes
Study Arms (2)
Experimental Group
EXPERIMENTALTelerehabilitation asynchronous programme at home
Control Group
ACTIVE COMPARATORRehabilitation programme with an explanatory booklet at home
Interventions
Home-based physical rehabilitation programme using a telerehabilitation platform
Home-based physical rehabilitation programme by means of an explanatory booklet
Eligibility Criteria
You may qualify if:
- Age range 18-75 years.
- Patients who have been hospitalized for more than 5 days for COVID-19.
- Patients who have been discharged from the hospital and present a fatigue score higher than 4 points on average on the fatigue severity scale (FSS).
- Independent walking, even with the use of any technical aid.
- Have signed the informed consent form.
You may not qualify if:
- Patients with central and/or peripheral neurological diseases that prevent the programme from being followed.
- Patients with rheumatic pathology or acute musculoskeletal injury in their medical history.
- Patients with severe respiratory failure: SaO2 less than 90% or respiratory rate \>30.
- Patients with cardiac comorbidities or signs of cardiovascular inestability as uncontrolled arrythmia, blood pressure and/or effort angina.
- Patients with other contraindicated pathology for moderate-intensity aerobic or strength exercise.
- Patients without access to mobile internet or computer with internet at home.
- Patients with a score ≤24 on the Mini-Cognitive Examination (MEC).
- Patients who are unable to follow oral and written instructions in Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad San Jorgelead
- Hospital Real Nuestra Señora de Graciacollaborator
- Hospital Royo Villanovacollaborator
Study Sites (2)
Hospital Real Nuestra Señora de Gracia
Zaragoza, 50004, Spain
Hospital Royo Villanova
Zaragoza, 50007, Spain
Related Publications (3)
Carpallo-Porcar B, Calvo S, Perez-Palomares S, Blazquez-Perez L, Brandin-de la Cruz N, Jimenez-Sanchez C. Perceptions and Experiences of a Multimodal Rehabilitation Program for People With Post-Acute COVID-19: A Qualitative Study. Health Expect. 2025 Jun;28(3):e70283. doi: 10.1111/hex.70283.
PMID: 40302157DERIVEDCarpallo-Porcar B, Calvo S, Alamillo-Salas J, Herrero P, Gomez-Barrera M, Jimenez-Sanchez C. An Opportunity for Management of Fatigue, Physical Condition, and Quality of Life Through Asynchronous Telerehabilitation in Patients After Acute Coronavirus Disease 2019: A Randomized Controlled Pilot Study. Arch Phys Med Rehabil. 2024 Aug;105(8):1439-1448. doi: 10.1016/j.apmr.2024.04.014. Epub 2024 May 4.
PMID: 38710426DERIVEDCarpallo-Porcar B, Romo-Calvo L, Perez-Palomares S, Jimenez-Sanchez C, Herrero P, Brandin-de la Cruz N, Calvo S. Efficacy of an asynchronous telerehabilitation program in post-COVID-19 patients: A protocol for a pilot randomized controlled trial. PLoS One. 2022 Jul 19;17(7):e0270766. doi: 10.1371/journal.pone.0270766. eCollection 2022.
PMID: 35853037DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolina Jiménez Sánchez, MD
Universidad San Jorge
- PRINCIPAL INVESTIGATOR
Sandra Calvo, Dr
Universidad San Jorge
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2021
First Posted
March 11, 2021
Study Start
April 5, 2021
Primary Completion
June 13, 2022
Study Completion
December 1, 2022
Last Updated
April 11, 2023
Record last verified: 2022-03